Condition: Gynecologic Cancer · Immunotherapy · Gut Microbiome · Sponsor: Viome
30 participants with advanced or recurrent gynecological cancer from are enrolled for this study. Eligible participants then provide fecal specimen, blood, vaginal swab, oral mucosal swab and receive food dietary recommendation. Additional samples are collected for results analysis.
This description comes directly from the study's public registry record.
Momchilo Vuyisich, PhD · 855 958 4663 · studies@viome.com
Ryan Toma, MS
Always discuss trial participation with your own doctor first.
| AdventHealth Cancer Institute | Orlando, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04957511